A composite 18F-FDG PET/CT and HER2 tissue-based biomarker to predict response to neoadjuvant pertuzumab and trastuzumab in HER2-positive breast cancer (TBCRC026)

作者：Ashley Cimino‐Mathews, Antonio C. Wolff, Richard L. Wahl, Vandana G. Abramson, Jodi M. Carter, Lisa A. Carey, Mothaffar F. Rimawi, Eric P. Winer, Vered Stearns, Jennifer M. Specht, Jeffrey P. Leal, Rita Denbow, E. Aubrey Thompson, Christos Vaklavas, Vincente Valero, Roisín M. Connolly, Ian E. Krop, Yaohua Ma, Jennifer M. Kachergus, Chiung‐Yu Huang, Maeve Hennessy, Lilja B. Sólnes, Anna Maria Storniolo · 发表于：UNC Libraries · 年份：2026 · DOI：10.17615/9tp3-0z02 · 研究领域：HER2/EGFR in Cancer Research、Medical Imaging Techniques and Applications、Breast Cancer Treatment Studies